BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brundin L, Björkqvist M, Träskman-bendz L, Petersén Å. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. Journal of Affective Disorders 2009;113:179-82. [DOI: 10.1016/j.jad.2008.04.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Gołyszny M, Zieliński M, Paul-samojedny M, Filipczyk Ł, Pałasz A, Obuchowicz E. Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats. Neuroscience Research 2022. [DOI: 10.1016/j.neures.2022.02.005] [Reference Citation Analysis]
2 Mikrouli E, Wörtwein G, Soylu R, Mathé AA, Petersén Å. Increased numbers of orexin/hypocretin neurons in a genetic rat depression model. Neuropeptides 2011;45:401-6. [PMID: 21871662 DOI: 10.1016/j.npep.2011.07.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
3 Liu Z, Zhang Y, Zhao T, Wang J, Xia L, Zhong Y, Yang Y, Ning X, Zhang Y, Ren Z, Liu H. A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms. Nordic Journal of Psychiatry 2020;74:525-32. [DOI: 10.1080/08039488.2020.1755995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chien Y, Liu C, Shan J, Lee H, Hsieh MH, Hwu H, Chiou L. Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms. Psychoneuroendocrinology 2015;53:1-9. [DOI: 10.1016/j.psyneuen.2014.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
5 McGregor R, Wu MF, Barber G, Ramanathan L, Siegel JM. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J Neurosci 2011;31:15455-67. [PMID: 22031892 DOI: 10.1523/JNEUROSCI.4017-11.2011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
6 Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. Journal of Affective Disorders 2011;131:186-92. [DOI: 10.1016/j.jad.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
7 Li H, Lu J, Li S, Huang B, Shi G, Mou T, Xu Y. Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients. Front Psychiatry 2021;12:676336. [PMID: 34135789 DOI: 10.3389/fpsyt.2021.676336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li X, Ge H, Zhou D, Wu X, Qi G, Chen Z, Yu C, Zhang Y, Yu H, Wang C. Reduced serum VGF levels are linked with suicide risk in Chinese Han patients with major depressive disorder. BMC Psychiatry 2020;20:225. [PMID: 32398015 DOI: 10.1186/s12888-020-02634-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
10 Schmidt FM, Brügel M, Kratzsch J, Strauß M, Sander C, Baum P, Thiery J, Hegerl U, Schönknecht P. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neuroscience Letters 2010;483:20-2. [DOI: 10.1016/j.neulet.2010.07.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
11 Deats SP, Adidharma W, Lonstein JS, Yan L. Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency. Neuroscience 2014;272:252-60. [PMID: 24813431 DOI: 10.1016/j.neuroscience.2014.04.069] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
12 Nollet M, Leman S. Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention. CNS Drugs 2013;27:411-22. [DOI: 10.1007/s40263-013-0064-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
13 James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
14 Walker LC, Ch’ng SS, Lawrence AJ. Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances. Curr Pharmacol Rep 2016;2:241-52. [DOI: 10.1007/s40495-016-0069-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Adidharma W, Deats SP, Ikeno T, Lipton JW, Lonstein JS, Yan L. Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus. Horm Behav 2019;116:104584. [PMID: 31445011 DOI: 10.1016/j.yhbeh.2019.104584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Nollet M, Gaillard P, Tanti A, Girault V, Belzung C, Leman S. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology 2012;37:2210-21. [PMID: 22713907 DOI: 10.1038/npp.2012.70] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 9.1] [Reference Citation Analysis]
17 Kripke DF. Is suvorexant a better choice than alternative hypnotics? F1000Res 2015;4:456. [PMID: 26594338 DOI: 10.12688/f1000research.6845.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
18 Song J, Kim E, Kim CH, Song HT, Lee JE. The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain 2015;8:16. [PMID: 25884812 DOI: 10.1186/s13041-015-0106-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
19 Boddum K, Hansen MH, Jennum PJ, Kornum BR. Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length. PLoS One 2016;11:e0151288. [PMID: 27008404 DOI: 10.1371/journal.pone.0151288] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
20 Vaseghi S, Zarrabian S, Haghparast A. Reviewing the role of the orexinergic system and stressors in modulating mood and reward-related behaviors. Neurosci Biobehav Rev 2021;133:104516. [PMID: 34973302 DOI: 10.1016/j.neubiorev.2021.104516] [Reference Citation Analysis]
21 Blouin AM, Fried I, Wilson CL, Staba RJ, Behnke EJ, Lam HA, Maidment NT, Karlsson KÆ, Lapierre JL, Siegel JM. Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun 2013;4:1547. [PMID: 23462990 DOI: 10.1038/ncomms2461] [Cited by in Crossref: 142] [Cited by in F6Publishing: 133] [Article Influence: 15.8] [Reference Citation Analysis]
22 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
23 Constantinescu CS, Niepel G, Patterson M, Judd A, Braitch M, Fahey AJ, Harikrishnan S, Edwards LJ, Tench CR, Bennett GW, Ghatei M. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness. J Neurol Sci 2011;307:127-31. [PMID: 21605873 DOI: 10.1016/j.jns.2011.04.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
24 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
25 Yan L, Lonstein JS, Nunez AA. Light as a modulator of emotion and cognition: Lessons learned from studying a diurnal rodent. Horm Behav 2019;111:78-86. [PMID: 30244030 DOI: 10.1016/j.yhbeh.2018.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
26 Bao AM, Ruhé HG, Gao SF, Swaab DF. Neurotransmitters and neuropeptides in depression. Handb Clin Neurol 2012;106:107-36. [PMID: 22608619 DOI: 10.1016/B978-0-444-52002-9.00008-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
27 Schöpf V, Fischmeister FP, Windischberger C, Gerstl F, Wolzt M, Karlsson KÆ, Moser E. Effects of individual glucose levels on the neuronal correlates of emotions. Front Hum Neurosci 2013;7:212. [PMID: 23734117 DOI: 10.3389/fnhum.2013.00212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett R, Pan Z, Brietzke E, Mcintyre RS. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:1-7. [DOI: 10.1016/j.pnpbp.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
29 Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011;61:336-46. [PMID: 21530551 DOI: 10.1016/j.neuropharm.2011.04.022] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
30 Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
31 Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
32 Serafini G, Pompili M, Lindqvist D, Dwivedi Y, Girardi P. The role of neuropeptides in suicidal behavior: a systematic review. Biomed Res Int 2013;2013:687575. [PMID: 23986909 DOI: 10.1155/2013/687575] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
33 Lindqvist D, Janelidze S, Erhardt S, Träskman-bendz L, Engström G, Brundin L. CSF biomarkers in suicide attempters - a principal component analysis: CSF biomarkers in suicide attempters. Acta Psychiatrica Scandinavica 2011;124:52-61. [DOI: 10.1111/j.1600-0447.2010.01655.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
34 Gao H, Li J, Zhao N, Zhang L, Fu Y, Zhang Y, Chen R, Zhang J. Biobehavioral effects produced by paternal sleep disturbances: Paternal sleep disturbances. Sleep and Biological Rhythms 2015;13:235-41. [DOI: 10.1111/sbr.12109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Khairuddin S, Aquili L, Heng BC, Hoo TLC, Wong KH, Lim LW. Dysregulation of the orexinergic system: A potential neuropeptide target in depression. Neuroscience & Biobehavioral Reviews 2020;118:384-96. [DOI: 10.1016/j.neubiorev.2020.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hou Y, Liu Y, Liu C, Yan Z, Ma Q, Chen J, Zhang M, Yan Q, Li X, Chen J. Xiaoyaosan regulates depression‐related behaviors with physical symptoms by modulating Orexin A/OxR1 in the hypothalamus. Anat Rec 2020;303:2144-53. [DOI: 10.1002/ar.24386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
38 James MH, Campbell EJ, Walker FR, Smith DW, Richardson HN, Hodgson DM, Dayas CV. Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats. Front Behav Neurosci 2014;8:244. [PMID: 25100956 DOI: 10.3389/fnbeh.2014.00244] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
39 Holsboer F, Ising M. Hypothalamic stress systems in mood disorders. Handb Clin Neurol 2021;182:33-48. [PMID: 34266603 DOI: 10.1016/B978-0-12-819973-2.00003-4] [Reference Citation Analysis]
40 Gołyszny M, Obuchowicz E. Are neuropeptides relevant for the mechanism of action of SSRIs? Neuropeptides 2019;75:1-17. [DOI: 10.1016/j.npep.2019.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
41 Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y. Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide. Neuropsychiatr Dis Treat 2019;15:2893-900. [PMID: 31632037 DOI: 10.2147/NDT.S219962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H. Reduced plasma orexin-A levels in patients with bipolar disorder. Neuropsychiatr Dis Treat 2019;15:2221-30. [PMID: 31496705 DOI: 10.2147/NDT.S209023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]